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Abstract 
This study describes the design and implementation of a new chromatographic descriptor called log k’80 
PLRP-S that provides information about the lipophilicity of drug molecules in nonpolar environment, both in 
their neutral and ionized form.  
The log k’80 PLRP-S obtained on a polymeric column with acetonitrile/water mobile phase is shown to 
closely relate to logPtoluene (toluene dielectric constant ε ~ 2).  
The main intermolecular interactions governing log k’80 PLRP-S were deconvoluted using the Block 
Relevance (BR) analysis. The information provided by this descriptor compared to ElogD and calclog Ptol 
and the differences are highlighted. 
The “charge-flush” concept is introduced to describe the sensitivity of log k’80 PLRP-S to ionization state of 
compounds in pH range 2 to 12. 
The ability of log k’80 PLRP-S to indicate the propensity of neutral molecules and monoanions to form 
Intramolecular Hydrogen Bonds (IMHBs) is proven through a number of examples. 
 
Keywords 
Nonpolar environments, Block Relevance analysis, drug candidates, ElogD, log Ptol, log k’80 PLRP-S, 
lipophilicity. 
 
Abbreviations 
BR: Block Relevance 
COSMO-RS: COnductor like Screening MOdel for Real Solvents 
IMHB: Intramolecular Hydrogen Bonding 
PCA: Principal Component Analysis 
PLS: Partial Least Squares 
PLRP-S: polystyrene/divinylbenzene polymeric column 
QSAR: Quantitative Structure-Activity Relationships 
QSPR: Quantitative Structure-Property Relationships 
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Introduction 
The lipophilicity descriptors determined in the n-octanol/water biphasic system (e.g. log Poct and log Doct) are 
routinely used by medicinal chemists to optimize the drug-like properties of hits and leads in the various 
steps of the drug discovery process.1 However, many interactions by the drug molecules are taking place in 
multilayered compartments, such as biological membranes. There is a need to support log Poct and log Doct 
with additional indexes that describe the affinity of molecules for specific physiological environments. For 
example, the central portion of the biomembranes, characterized by low dielectric constant (~ 2) ,2,3 cannot 
be adequately modeled by n-octanol (dielectric constant ~ 10). The lipophilicity descriptors which could 
characterize the compound properties in the core of biological membranes are expected to be of great 
relevance to drug discovery programs.4 
The most common descriptor to evaluate lipophilicity in nonpolar environments is log Palk. Unfortunately, 
this descriptor is largely inaccessible for many drug candidates due to their poor solubility in the alkane 
phase. The log Ptol has been recently proposed as a valuable alternative5  to log Palk due to better solubility in 
toluene.  Moreover, we have tested COSMO-RS software and demonstrated that it is a reliable tool for log 
Ptol prediction.5 Nevertheless, the “shake-flask” methodology, in general, is limited by the difficulty of 
quantification in organic or water phases, especially for -3<log P>3. HPLC-based methods6 have helped to 
overcome the limitations stated above and have gained broad acceptance for lipophilicity assessment.  
Indeed, chromatographic systems can be easily set-up with a variety of available stationary and mobile 
phases to reproduce a number of biological environments.7 For instance, ElogD is a widely accepted RP-
HPLC method for log Doct determination; 8 and EPSA 9 is a Supercritical Fluid Chromatography (SFC) 
method describing exposed polarity of the molecule in low dielectric constant environment. A few studies 
have been published over the years suggesting that the polymeric columns10,11,12,13 could be useful for 
characterization of drug candidates. 
In this study we describe a chromatographic system with polystyrene/divinylbenzene polymeric column 
(PLRP-S) and introduce the lipophilicity index based on retention in that system called log k’80 PLRP-S, 
where 80 is referring to the percentage of the aprotic acetonitrile in the mobile phase.   
In order to characterize the system we applied the recently developed Block Relevance (BR) analysis tool,14 
which allowed the analysis of the balance of intermolecular interactions governing the retention using 
common 3D-QSAR/QSPR descriptors. These descriptors are aggregated into property-related groups 
(blocks), thus providing a convenient framework for comparison and interpretation of descriptors determined 
in different systems, for example ElogD, vs. logPtol, vs. log k’80 PLRP-S. Furthermore, the stability of 
PLRP-S polymeric column under a wide range of pH conditions (1 – 12) is an important feature of this type 
of stationary phase and we wanted to explore its advantages for characterizing ionizable compounds. 
The goals of this study can be summarized in three areas: 
1. Establish the relationship between log k’80 PLRP-S and other lipophilicity descriptors (ElogD 8 and 
calclog Ptol 5) using a representative set of neutral compounds, including common drugs.  
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2. Investigate the sensitivity of the new descriptor to compounds propensity to form intramolecular hydrogen 
bonds (IMHBs). The log k’80 PLRP-S values were compared for the pairs of structural analogs capable and 
not-capable of IMHB, similar to the previously established ΔlogP approach,12 and the capabilities for IMHB 
detection are reported. 
3. Verify that the system provides information on the state of ionization of compounds at different pHs. Here 
a fairly large set of ionizable commercial drugs was assembled, for which we determined and analyzed log 
k’80 PLRP-S at acidic, neutral and basic pHs. The unique feature of the PLRP-S system to relate the 
ionization state of the molecules in a low dielectric constant environment, similar to biomembranes, is 
identified and described.  
Taken together, these results suggest that log k’80 PLRP-S is a descriptor that allows estimation of 
lipophilicity of neutral and ionized species in nonpolar matrix and deserve being included in drug discovery 
strategies. 
 
Experimental Section 
The datasets 
The selection of the panel of compounds to investigate and set-up a new method to be integrated in drug 
discovery programs is not a trivial issue. Simple organic compounds are very helpful for the mechanistic 
interpretation of the phenomenon, but they cover a limited chemical space. Commercial drugs, on the other 
hand, enable the enlargement of the chemical space and thus should be included. Furthermore, the internal 
data sets are required to demonstrate the practical application of the method to the chemical space explored 
by the current drug design projects. 
The first dataset was comprised of 44 neutral compounds, which includes simple organic molecules, 
commercial drugs and internal compounds (Table 1). Chemical structures can be downloaded from 
https://sites.google.com/site/cassmedchem/download-area/plrps-dataset. 
None of these compounds have any propensity to form IMHBs and are predominantly neutral at pH 7. The 
dataset diversity was explored using Principal Component Analysis (PCA). The scores and loadings plots 
resulting from PCA analysis using 82 VolSurf+ descriptors are reported in Figures S1A and S1B (Supporting 
Information), respectively. In order to check for the diversity of the chemical space covered by this dataset 
we made a comparison with the Skold’s dataset,15 which was proposed as a gold standard for 
physicochemical pharmaceutical profiling. The PCA analysis showed that the chemical space covered by the 
44 neutral compounds was comparable to Skold’s dataset (data not shown).  
The second dataset consists of 5 pairs (10 compounds) capable and incapable of forming IMHBs.5 The 
chemical structures are shown in Figure 3. 
The third dataset was composed of 76 commercial drugs (Table 3). This dataset includes drugs in various 
states of ionization and a wide range of pKa values. Molecular properties were calculated (e.g. log D7.4, 
number of HBD/HBA groups, rotatable bonds, etc.) to assess the chemical diversity of compounds present in 
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the dataset (data not shown). Chemical structures can be downloaded from 
https://sites.google.com/site/cassmedchem/download-area/plrps-dataset. 
Chromatographic measurements 
log k’80 PLRP-S 
Measurements were performed using an Agilent 1290 HPLC instrument with diode array and quadrupole 
mass-spec 6140 detectors. The UV signals were monitored at 215, 254, 280 and 310 nm and MS detection by 
ES API in positive mode. The retention time from the UV signal was used throughout for consistency, unless 
noted. The PLRP-S column, 100 A, 5 uM, 50x4.6mm; part# PL1512-1500 from Agilent was used with the 
mobile phase flow rate 1 mL/min. 
The mobile phase was prepared by mixing 80% acetonitrile and 20% of aqueous portion, which contained 
the total amount of the buffer. The aqueous buffers were chosen to cover pH range from 2 to 11 and also to 
be compatible with mass-spec detection: 0.1% formate buffer; 0. 1% ammonium acetate and 10 mM 
triethylamine. 
Astemizole was used as t0 marker (RT= 0.3 min.) at pH~2 and valsartan (RT= 0.29 min.) at pH~10. We used 
t0=0.3 min. throughout for consistency in calculations of the capacity factor k. 
The log k’80 PLRP-S standard deviation determined on two columns on a set of 49 compounds form the first 
and second datasets, measured 3 times, was 0.021.  
ElogD 
ElogD measurements were performed as previously described.8 Briefly, ElogD values obtained from logk’w 
determined on Supelcosil LC-ABZ column using MOPS buffer and methanol mobile phase at pH 7.4. 
NMR measurements 
The proton chemical shift 1H NMR values used here were determined in CDCl3 and DMSO-d6 as previously 
described. 5,16   
pH measurements 
Agilent 3200P pH meter and P3211 combination electrode calibrated with aqueous standards were used for 
pH measurements. The pH of the aqueous portion of the mobile phase was measured and recorded, and then 
80% of acetonitrile added. The swpH (pH measured in acetonitrile/water with the electrode calibrated in 
water) of the mobile phase was measured after the mixture equilibrated to the room temperature. 
In silico tools 
Propensity to form IMHBs 
An in-house software17 was used to identify compounds with propensity to form intramolecular hydrogen 
bonds (IMHB) according to the topologies proposed by Kuhn and coworkers.18  
pKa calculations 
pKa calculations were performed using MoKa (Molecular Discoveries, Ltd, v.2.5.4 ) and ACDlabs Percepta 
v. 12.1. 
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COSMO-RS calculations of log Ptol data 
log Ptol calculations were performed using COSMO-RS software as previously described.5 
VS+ models 
VS+ models were built by submitting the SMILES codes of the compounds to VS+ (version 1.0.7, 
http://www.moldiscovery.com) using default settings and four probes (OH2, DRY N1 and O probes that 
mimic respectively water, hydrophobic, HBA and HBD properties of the environment). PCA and PLS tools 
implemented in VS+ were used.  
BR analysis 
BR analysis was performed as described elsewhere.14,17 Briefly, BR analysis allows useful interpretation of 
PLS models by organizing the VS+ descriptors into six blocks (Size, Water, DRY, N1, O and Others) of 
straightforward significance. The definitions and details are given in Figure 1B. In a very simplistic way, BR 
analysis gives the relevance of each parameter (block) to the model. 
Processing was done on two 8 cores Xeon E5 at 3.3GHz CPUs and 128GB of RAM. 
 
Results 
The PLRP-S system characterization 
A set of 44 compounds, mostly neutral at pH 7, with no propensity to form IMHBs, was selected for the 
comparative analysis of the chromatographic system consisting of a) a PLRP-S column made of 
polystyrene–divinylbenzene copolymer as a stationary phase and b) a mobile phase made by mixing 80% 
ACN and 20% aqueous buffer. 
The obtained descriptor is named log k’80 PLRP-S and defined as follows: 
 
log k’80 PLRP-S = log ((tR - t0)/t0)  
 
where k’80 PLRP-S is the retention factor, tR is the retention time and t0 is the column dead time. 
The full list of experimental log k’80 PLRP-S is reported in Table 1. For comparative purposes ElogD 8 and 
calculated logPtol 5 (calclog Ptol) values are also reported here.  
Table 1 reveals that log k’80 PLRP-S covers a range of 1.25 logarithmic units which is significantly smaller 
than those covered by ElogD (5.16) and calclog Ptol (7.91).  
 
Table 1. Dataset investigated for comparative characterization of PLRP-S system. The compounds listed 
with letters and numbers reflect the original assignments made in the previous studies. 5,16 
 
Compounds log k'80 PLRP-S ElogD calclog Ptol 
1-naphthol 0.34 3.17 1.58 
2-naphthol 0.29 3.01 1.37 
3,5-dichlorophenol 0.46 3.88 1.1 
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3-bromoquinoline 0.84 2.93 3.36 
3-chlorophenol 0.26 3.11 0.64 
3-nitroaniline 0.34 1.52 1.31 
3-nitrophenol 0.24 2.22 0.2 
4-toluidine 0.32 1.48 1.55 
Acetophenone 0.40 1.58 1.88 
Aniline 0.26 0.69 1.07 
Antipyrine -0.04 0.23 0.58 
Bifonazole 0.67 4.95 4.74 
Bromazepam 0.22 1.38 1.52 
cA5 0.36 2.68 2.44 
caffeine -0.04 -0.21 -0.32 
carbamazepine 0.09 2.01 0.98 
cB5 0.64 2.58 3.76 
cD5 0.10 1.84 1.09 
cE15 0.16 2.11 0.99 
cF5 0.05 1.3 -0.43 
cH5 0.36 1.65 2.69 
clotrimazole 0.65 4.69 4.66 
dexamethasone 0.10 2.37 0.76 
diazepam 0.50 3.03 3.34 
diethylstilbestrol 0.35 4.72 2.03 
estradiol 0.29 3.82 1.62 
griseofulvin 0.26 2.57 2.35 
hydrocortisone -0.01 1.71 -0.06 
hydrocortisone-21-acetate 0.20 2.26 0.26 
lorazepam 0.19 2.74 1.58 
lormetazepam 0.34 2.78 2.91 
naphthalene 0.98 3.62 3.71 
nefazadone 1.21 4.95 6.49 
nifedipine 0.29 2.85 2.94 
nifuroxime 0.11 1.36 -0.06 
pentoxifylline 0.09 0.31 0.2 
616 0.01 -0.1 -1.06 
phenol 0.16 1.49 0.21 
prednisolone 0.09 1.83 -0.55 
prednisone 0.09 1.47 0 
quinoline 0.42 1.85 1.96 
testosterone 0.30 3.15 1.3 
thymol 0.38 3.65 2.75 
tolnaftate 1.16 5.15 6.85 
 
Data in Table 1 were used to build the first QSPR model by splitting up the dataset into a training set (n =33) 
and a test set (n =11). Experimental log k’80 PLRP-S values were imported into VS+ as response variables 
(Y, the property) and a relation between Y and the 82 VS+ molecular descriptors (X, the structure) was 
sought using the PLS algorithm implemented in the software. A model was found (R2 = 0.87, Q2 = 0.53, 
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Table 2) and the correlation between calculated and experimental values (R2 = 0.87) is shown in Figure S2 
(Supporting Information). The external validation of the PLS model using the test set was also performed. 
Predictions are shown in Figure S2 (R2= 0.84, Supporting Information) and support the statistical stability of 
the model.  
 
Table 2. PLS models (N = number of observations, R2 = cumulative determination coefficient, Q2 = cross-
validated correlation coefficient, LV = number of latent variables, SDEP = standard error on the 
prediction). 
System N R2 Q2 LV SDEP 
log k’80 PLRP-S 33 0.87 0.53 4 0.22 
ElogD 33 0.89 0.67 4 0.80 
calclog Ptol 33 0.90 0.67 4 1.04 
log k’80 PLRP-S 44 0.86 0.63 4 0.17 
ElogD 44 0.89 0.78 4 0.62 
calclog Ptol 44 0.89 0.74 4 0.88 
 
Since the external validation procedure gave excellent results, a second PLS model based on all 44 
compounds was built (Table 2, R2=0.86, Q2=0.63) and used as a starting point for the BR analysis. 14,17,19,20,21  
BR analysis graphical output for log k’80 PLRP-S is reported in Figure 1A. The meaning and significance of 
the blocks is reported in Figure 1B to help with interpretation of parameters. 
Figure 1A outlines the major role played by the Size block (green) in log k’80 PLRP-S values. Moreover, it 
shows that the Size block (green) and the O block (related to HBD solutes’ properties) are almost entirely 
attributed either to positive or negative portions, respectively. 
 
Figure 1. BR analysis graphical outputs: A) log k’80 PLRP-S, B) block significance, C) ElogD and D) 
calclog Ptol 
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Relationship with other systems 
ElogD is a validated method for log Doct measurements.8 The BR analysis of ElogD data was obtained using 
the same procedure as described above for log k’80 PLRP-S. The results are shown in Figure 1C and outline 
the major role played in ElogD by the Size block (green). Moreover, all, but the Size block, are split in 
positive and negative portions. In addition, the relationship between ElogD and log k’80 PLRP-S for the 
dataset listed in Table 1 is shown in Figure 2A (R2 = 0.54).  
 
Figure 2. Relationship between log k’80 PLRP-s and A) ElogD and B) calclog Ptol 
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The calclog Ptol values reported in Table 1 were calculated using COSMO-RS. BR analysis output for 
calclog Ptol data is shown in Figure 1D, where solutes’ Size (green) is the dominant block. The Hydrogen 
Bonds related blocks (red and blue) have mostly negative weighting. Finally, Figure 2B reports the 
relationship between log k’80 PLRP-S and calclog Ptol and R2 is found to be 0.82.  
log k’80 PLRP-S and IMHBs of the neutral species 
log k’80 PLRP-S for the selected pairs of compounds (the second dataset, see Experimental Part) are 
reported in Figure 3. Results show that all compounds with propensity to form IMHBs (denoted as S, 
samples), are more retained than compounds with no propensity to form IMHB (denoted as C, controls). The 
1H NMR chemical shifts of the pairs in DMSO-d6 are also presented here for validation purposes. In 
particular, the 1H chemical shifts of the proton potentially involved in the formation of IMHBs were 
monitored (data in Figure 3).5,16  A downfield shift was always observed in the samples containing IMHBs 
compared to the controls. For instance, the amide proton of c10 linked to the aromatic ring shows a 
downfield shift compared to the corresponding proton in cD (10.51 and 8.25, respectively).  
The 1H NMR chemical shifts in CDCl3 were also obtained on some pairs (Table S1 in Supplemental Info), 
however, due to solubility issues in CDCl3, only values measured in DMSO-d6 are available for all studied 
compounds. The DMSO-d6 dielectric constant is approximately 47, and it is much more polar compared to 
chloroform, or to the cell membranes environment. The formation of IMHB in DMSO-d6 requires stronger 
interactions compared to a less polar environment. The PLRP-S system is different in polarity compared to 
DMSO-d6 or CDCl3, however, the results demonstrate that IMHB observed in DMSO-d6 and CDCl3 (where 
available) are also observed in the PLRP-S system. 
 
Figure 3. Pairs (C = control, S = sample) selected to show the application of log k’80 PLRP-S to detect the 
presence of intramolecular hydrogen bonds. 1H NMR chemical shifts of the proton potentially involved in the 
formation of IMHBs are shown for validation purposes. Compounds lettering and numbering reflect the 
original assignments made in the previous studies.5,16 
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The ionized species interactions in the PLRP-S system 
Since most drugs are partly or fully ionized at physiological pHs, we extended the study to include 76 drugs 
in various states of ionization and measured log k’80 PLRP-S at neutral, acidic and basic pHs. The pH 
measured in water-organic mixture produced apparent swpH values. These values are not adjusted for the 
presence of the organic co-solvent and are different from pH measured in the aqueous portions of the buffer 
(pH values measured in aqueous and co-solvent mixtures are given in Table S2 in Supplemental 
Information). The apparent swpH values are used throughout here, since the mobile phases were prepared 
with the same amount of acetonitrile, 80%.  In addition, the gradient was avoided, as not to change the 
amount of organic modifier, which could affect the ionization of the compounds and all studies were 
performed at isocratic chromatographic conditions.  
The data are shown in Table 3. The compounds are distinguished in four groups on the basis of their 
ionization state at pH 7, estimated according to MoKa’s pKa predictions: neutral drugs (= predominantly 
neutral at pH 7), acids (=predominantly negatively charged at pH 7), bases (=predominantly positively 
charged at pH 7) and three compounds (cetirizine, levodopa and methotrexate) with more complex ionization 
profiles. 
 
Table 3. log k’80 PLRP-S at different pH conditions (acidic, neutral and basic) for the series of 76 
compounds. The dominant species (by MoKa calculations) at specified pH are also reported. 
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Compound 
log k’80 
PLRP-S 
(swpH 3) 
log k’80 
PLRP-S 
(swpH 7.7) 
log k’80 
PLRP-S 
(swpH 11) 
Ionization at 
pH = 2 
Ionization 
at pH 7 
Ionization at 
pH = 11 
N
eu
tr
a
ls
 
Alfentanil -0.17 0.22 0.24 +1 0 0 
Antipyrine -0.04 -0.04 -0.01 0 0 0 
Caffeine -0.05 -0.04 -0.02 0 0 0 
Carbamazepine 0.10 0.09 0.11 0 0 0 
Cimetidine -0.94 -0.16 -0.14 +1 0 0 
Colchicine -0.07 -0.08 -0.05 0 0 0 
Corticosterone 0.13 0.11 0.15 0 0 0 
Cyclosporin A 0.31 0.29 0.31 0 0 0 
Diazepam 0.48 0.47 0.50 0 0 0 
Etoposide -0.10 -0.09 -1.26 0 0 0 
Hydrocortisone -0.03 -0.01 0.01 0 0 0 
Indinavir -1.18 -0.01 0.01 +2 0/+1** -1 
Paclitaxel 0.15 0.12 0.16 0 0 0 
Phenytoin 0.02 0.01 -0.75 0 0 -1 
Ritonavir 0.15 0.14 0.15 +2 0 0 
Testosterone 0.31 0.30 0.32 0 0 0 
Theophylline -0.13 -0.12 -0.81 0/+1 0 -1 
Trazodone -1.06 0.45 0.47 +1 0/+1** 0 
Zidovudine -0.12 -0.11 -0.25 0 0 -1 
A
ci
d
s 
Atorvastatin 0.10 -0.12 -1.03 0 -1 -1 
Entacapone 0.05 -0.15 -0.64 0 -1 -2 
Flurbiprofen 0.29 -0.10 -1.10 0 -1 -1 
Furosemide -0.03 -0.21 -1.14 0 -1 -2 
Ibuprofen 0.27 -0.03 -1.08 0 -1 -1 
Indomethacin 0.37 -0.06 -1.08 0 -1 -1 
Naproxen 0.21 -0.09 -1.10 0 -1 -1 
Nitecapone 0.01 -0.19 -0.66 0 -1 -2 
Phenylbutazone 0.10 -0.08 -1.05 0 -1 -1 
Probenecid 0.13 -0.20 -1.08 0 -1 -1 
Salicylic acid 0.14 -0.22 -1.10 0 -1 -1 
Tolbutamide 0.10 -0.17 -0.97 0 -1 -1 
Tolcapone  0.25 -0.12 -0.61 0 -1 -2 
Valsartan 0.06 * * 0 -2 -2 
Warfarin 0.28 -0.12 -1.03 0 -1 -1 
B
a
se
s 
Amitriptyline -0.73 0.58 0.95 +1 +1 0 
Amoxapine -0.87 0.40 0.48 +2 +1 0 
Astemizole * 0.41 0.39 +2 +1 0 
Buspirone -0.98 0.42 0.44 +2 +1 0 
Chlorpromazine -0.79 0.91 1.26 +2 +1 0 
Citalopram -1.01 0.17 0.44 +1 +1 0 
Clozapine -1.01 0.45 0.47 +3 +1 0 
Codeine -1.06 0.02 0.05 +1 +1 0 
Diltiazem -0.93 0.31 0.37 +1 +1 0 
Diphenhydramine -0.93 0.24 0.53 +1 +1 0 
Domperidone -0.97 0.00 0.03 +1 +1 -1 
Fentanyl -0.89 0.49 0.60 +1 +1 0 
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Fluoxetine -0.97 0.18 0.52 +1 +1 0 
Galanthamine -1.08 0.02 0.09 +1 +1 0 
Haloperidol -0.97 0.38 0.46 +1 +1 0 
Imatinib -1.12 0.10 0.08 +4 +1 0 
Lidocaine -1.00 0.28 0.32 +1 +1 0 
Maprotiline -0.71 0.26 0.84 +1 +1 0 
Mesoridazine -1.01 0.25 0.47 +2 +1 0 
Methadone -0.90 0.23 0.93 +1 +1 0 
Metoclopramide -1.10 -0.04 0.14 +2 +2 0 
Mirtazapine -0.49 0.36 0.36 +2 +1 0 
Morphine -1.00 -0.08 -0.08 +1 +1 -1 
Oxycodone -1.15 0.21 0.35 +1 +1 0 
Perphenazine -0.81 0.66 0.67 +2 +1 0 
Propranolol -1.03 0.30 0.44 +1 +1 0 
Quinidine -1.13 0.40 0.23 +2 +1 0 
Quinine -1.06 0.39 0.20 +2 +1 0 
Risperidone -1.10 0.17 0.19 +2 +1 0 
Saquinavir -0.97 0.17 0.20 +1 +1 0 
Sertraline -0.77 0.75 1.09 +1 +1 0 
Sildenafil -1.03 0.20 -0.12 +2 +1 -1 
Sumatriptan -1.18 -0.10 -0.02 +1 +1 -1 
Terfenadine -0.81 0.43 0.84 +1 +1 0 
Thioridazine -0.72 0.96 1.37 +2 +1 0 
Venlafaxine -1.03 0.16 0.60 +1 +1 0 
Verapamil -1.00 0.33 0.52 +1 +1 -1 
O
th
er
s Cetirizine -0.66 -0.09 -1.02 +2 +1; -1*** -1 
Levodopa -0.41 -0.10 -1.26 +1 +1; -1*** -2 
Methotrexate -1.08 0.15 -2.46 +2 -2 -2 
*used to measure dead time, t0 (see the Experimental Section) 
**both species present at about 50% 
***zwitterions 
 
The log k’80 PLRP-S values listed in Table 3 are plotted vs pH in Figure 4 to help with interpretation of the 
results.  
 
Figure 4. The variation of log k’80 PLRP-S vs pH for drugs listed in Table 3: A) acids, B) bases and C) 
neutrals. The connecting lines are colored and enlarged for compounds highligted in the discussion. 
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Acids (Figure 4A) 
All investigated acids show a drop in log k’80 PLRP-S when the mobile phase pH moves from acidic to 
basic pHs. At the basic pH, where these molecules are predominantly in their anionic form, their log k’80 
PLRP-S is rather constant and close to -1.0. Entacapone, nitecapone and tolcapone show a peculiar behavior 
since their log k’80 PLRP-S value is about -0.6, significantly higher than those registered for other acids. 
Capones have two acidic centers (pKas about 5 and 9)22 and thus their dianionic forms are predominant at 
basic pHs. 
Bases (Figure 4B) 
Generally speaking, for most monobases the trend in Figure 4B is opposite to monoacids, i.e. the drop in log 
k’80 PLRP-S is found when passing from basic to acidic pHs. However, at the acidic pH, when monobases 
are expected to be mostly in their cationic form, log k’80 PLRP-S values vary for all drugs. Mirtazapine, 
which is expected to be diprotonated at acidic pH (Table 3), shows the higher value of log k’80 PLRP-S.  
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Mirtazapine, imatinib and morphine do not show any decrease in log k’80 PLRP-S when passing from basic 
to neutral pH. Mirtazapine and imatinib are expected to protonate when passing from basic to neutral pH. 
Conversely, morphine is expected to change its ionization state from -1 to +1 during this passage. 
Quinine, quinidine and sildenafil show an increase in log k’80 PLRP-S when passing from basic to neutral 
pH. For quinine and quinidine this corresponds to a passage from the neutral to the cationic species. For 
sildenafil the passage from basic to neutral conditions corresponds to a change in its protonation state from -
1 to +1. 
Neutrals (Figure 4C) 
For many neutral drugs log k’80 PLRP-S values were rather constant at any pH. Four drugs (alfentanil, 
cimetidine, trazodone and indinavir) show a drop in log k’80 PLRP-S at acidic pHs. MoKa predicts that at 
acidic pHs the four drugs are protonated. Ritonavir is also predicted diprotonated but log k’80 PLRP-S does 
not vary with the pH. Zidovudine, phenytoin, theophylline and etoposide show a drop in log k’80 PLRP-S at 
basic pHs. All but etoposide are expected to be negatively charged at basic pH. Indinavir has an opposite 
behavior compared to etoposide, since it is expected to be negatively charged at basic pH, but its log k’80 
PLRP-S does not vary with the pH. 
Other molecules 
The two zwitterions (cetirizine and levodopa) have consistent behavior. Cetirizine shows the largest log k’ 
80 PLRP-S when the zwitterion is the dominant species as shown in the literature.23 Levodopa shows a 
similar trend to cetirizine: the cation is largely more lipophilic than the anion, whereas the zwitterion is the 
most lipophilic species. Methotrexate has a more complex ionization profile and the zwitterionic species is 
barely present.24 
Discussion 
PLRP-S system set-up 
The choice of the column was made from the analysis of literature data. We evaluated the balance of the 
intermolecular interactions governing chromatographic retention in HPLC systems with polymeric columns 
described in the literature10 (data not shown) through the BR analysis (see below for details).14 We found that 
the retention on polymeric column is governed by the size of the solutes and, also, by the interactions 
between the hydrogen bond donor (HBD) properties of the solutes and the hydrogen bond acceptor (HBA) 
properties of the system. This is in line with the analysis recently reported in the literature for log Ptol ,17 
which is considered a relevant system for describing nonpolar environments. 
The mobile phase composition was chosen as a result of a number of considerations. Acetonitrile (ACN) was 
preferred for its aprotic nature, better interaction with the stationary phase and improved elution, resulting in 
better peak shape, compared to methanol-containing mobile phase, which demonstrated significant peak 
tailing. The composition of the mobile phase (80% ACN: 20% buffer) was selected to achieve the best 
compromise between speed and selectivity. The isocratic conditions were preferred over the gradient for a 
number of reasons. Firstly, we recently showed the influence of the changes in the mobile phase composition 
17 
 
in a gradient, on the balance of forces governing retention in a given system14 and we wanted to avoid such 
variability. Then we verified that 80% ACN ensured rapid elution, while still providing adequate separation. 
Finally, isocratic conditions were preferred for the application of a Quantitative Structure-Properties 
Relationships (QSPR) approach to characterize the system. 
log k’80 PLRP-S characterization and its relationship with calclog Ptol and ElogD 
Log k’80 PLRP-S was characterized using BR analysis output plots (Figure 1A). This tool provides 
information about the balance of the intermolecular interactions governing the system. In a BR plot, blocks 
with positive weighting (e.g. the green block in Figure 1A) show how much the property described by the 
block increases retention, whereas blocks with negative weighting (e.g., the red block) indicate how much 
the property decreases log k’80 PLRP-S values. The positive value of the Size block (green) in Figure 1A 
supports that larger compounds have longer retention under investigated PLRP-S conditions. This evidence 
is shared by all chromatographic RP systems.19 The Size and HBD solutes’ properties (O block, red) are 
almost entirely attributed either in positive or negative portions. That shows the modest noise and inter-
correlation of these descriptors and thus confirms their relevance to the model. In particular, the relevance of 
the red block supports the applicability of log k’80 PLRP-S to discriminate the propensity of candidates to 
form IMHBs, as described in detail below. 
For comparative purposes, we obtained ElogD and calclog Ptol for the same 44 neutral compounds chosen for 
characterizing the PLRP-S system. ElogD was selected since it is a chromatographic method widely 
appreciated for determining log D7.4 in the standard system, i.e. octanol/water. The presence of a relationship 
between log k’80PLRP-S and ElogD (R2 = 0.43) (Figure 2A) is mostly due to the solutes dimensions: the 
larger the compounds the easier they stay in the nonpolar phase. That is verified by BR analysis which shows 
a similar trend for the Size block present in both descriptors (Figure 1A and 1C).  
The log Ptol was selected as a second reference descriptor to compare log k’80 PLRP-S data with values 
obtained in nonpolar system. Measured log Ptol values are not available for many compounds in the dataset 
due to difficulties of measurements, as described in the literature 5 and we used calculated values for this 
reason. The linear regression in Figure 2B shows a slope significantly different from 1. However, BR 
analysis demonstrated that log k’80 PLRP-S and calclog Ptol (Figure1A and 1D) are governed by the similar 
balance of intermolecular forces between the solutes and the system.  
Identification of IMHB of neutral compounds using log k’80 PLRP-S 
The identification of compounds likely to form IMHBs is an important drug design consideration since it is 
related to increased membrane permeability.18 
NMR chemical shift is the most widely known tool25 for IMHB verification, albeit, it is often limited by the 
solubility issues.5 Δlog Poct-tol and EPSA techniques have recently gained relevance. However, the existing 
methods do not cover the variability of the physiological environments and log k’80 PLRP-S could serve as 
an additional tool.  
Given the relevance of the solutes HBD properties (red block) in Figure 1A, the PLRP-S system is expected 
to detect the presence of IMHBs. Indeed, the formation of IMHB “hides” the HB donor and HB acceptor of a 
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solute and that could be detected by the PLRP-S system. Similar to Δlog Poct-tol and EPSA methods, the log 
k’80 PLRP-S has to be used in a pair wise way to limit the interference of Size. That is clearly shown by the 
BR analysis above. Indeed, for a pair of close analogs we can assume that both control and sample have 
similar size and hydrophobic properties and thus their difference in log k’80 PLRP-S is mostly due to the 
difference in HBD properties. 
The experimental results for the selected pairs (data in Figure 3) showed that log k’80 PLRP-S values are 
differentiating the propensity of the investigated neutral compounds to form IMHBs. This is exemplified by 
the comparison of the cB (the control) and c6 (the sample) pair. 
A log k’80 PLRP-S of 0.15 was measured for cB. In the absence of IMHB c6 is expected to be more polar 
and thus less retained than cB. Since the log k’80 PLRP-S of c6 is 0.42, it supports the presence of IMHBs.  
The 1H NMR chemical shift analysis also provides evidence on the propensity of samples to form IMHBs. 
Interestingly, both log k’80 PLRP-S results and 1H NMR chemical shifts support formation of IMHB in all 
examined samples. Although, the two methods provide the information in different ways. For instance c10 
has modest propensity to form IMHBs according to log k’80 PLRP-S (little difference with its control, cD), 
but high propensity according to NMR data (large difference in the chemical shift). These variations could be 
ascribed to the differences in polarity of the two systems and in the balance of factors governing 
chromatographic retention and chemical shift. Δlog Poct-tol data analysis5 (as described in the Supporting 
Information, Table S2) also supports formation of IMHB in these compounds. 
Summing up, log k’80 PLRP-S can be combined with known tools such as Δlog Poct-tol 5 and EPSA 16 and 
also with 1H NMR data, to produce a reliable picture of how different physiological conditions modulate the 
propensity of neutral drug candidates to form IMHBs.  
Log k’80 PLRP-S and solutes ionization profiling across pHs 
The stability of the PLRP-S polymeric column under different pH conditions is an important feature of this 
type of stationary phase. That was already verified in a study which reported the retention factors of some 
ionizable compounds.26 We decided to explore the advantages of PLRP-S column stability for characterizing 
ionizable compounds.  
The “charge-flush” concept 
Figure 4 shows that PLRP-S system is very sensitive to the solutes ionization. Generally speaking, log k’80 
PLRP-S decreases when passing from pHs in which the neutral species is dominant to pHs in which the 
ionized species are mostly present. This finding gives the basis to define the “charge-flush” concept 
illustrated in Figure 4. In practice, the “charge-flush” concept highlights that under the studied PLRP-S 
conditions the fully charged compounds are poorly retained, hence “flushed”. 
Another observation evident from Figure 4 is different sensitivity of the PLRP-S system for positively and 
negatively charged compounds. In particular, in PLRP-S system, the monocations are generally more 
retained than monoanions. 
These findings could be used to obtain two kinds of information: a) verify predicted pKa; b) estimate the 
propensity of monoanions to form IMHBs. 
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Verification of pKa prediction 
In our experience the pKa prediction accuracy is often inadequate, especially, when more than one ionization 
center is present. The graphic representation reported in Figure 4 could help with analysis of experimental 
data in relation to ionization state across pH ranges. It should be noted that while MoKa pKa calculations are 
done in aqueous conditions, the logk’80 PLRP-S is determined in the presence of significant amount of 
acetonitrile in the mobile phase. MoKa and other pKa models are routinely used by medicinal chemists to 
estimate ionization of molecules, including in biological fluids and other physiological environments.  
Therefore, we considered it would be practical to relate the observed interactions to the aqueous ionization 
scale routinely used by the drug designers. 
Let’s take indinavir as an example from the neutral group. An acidic pKa of about 10.5 is predicted by 
MoKa. This is surprising since it is associated with an amide group. The experimental results show no 
decrease in log k’80 PLRP-S when passing from neutral to basic pH, which confirms that an acidic pKa, if 
present, has a higher value than the predicted 10.5. In another example, etoposide is predicted to be neutral 
along the entire pH scale by MoKa. However, the low log k’80 PLRP-S value registered at basic pH suggests 
that the phenolic OH is probably more acidic than expected. For ritonavir MoKa predicts two basic pKas 
(2.45 and 3.85), attributed to two thiazole nitrogens. Log k’80PLRP-S data confirm that the nitrogens are, 
probably, less basic, since measured values at pH 7 and pH 2 are very close (0.15 and 0.14, respectively), 
whereas a drop in log k’80 PLRP-S is expected in the presence of an additional ionized center.  
In a group of bases morphine also shows a strange behavior. At both neutral and acidic pHs it is expected to 
be monoprotonated, but its log k’80 PLRP-S is considerably higher at acidic pH (-0.08 vs -1.00, 
respectively). These experimental data could be justified by the presence of a zwitterionic species 27 not 
evidenced by MoKa calculations. Imatinib shows the same log k’80 PLRP-S at basic and neutral pHs, but 
this is not consistent with the predicted pKa values, which indicates that at pH = 7, the cation is the dominant 
species. In other words, the basic nitrogen (pKa 8.46) is less basic than predicted. Finally, mirtazapine seems 
to share the same behavior as imatinib. 
It could be argued that these differences are due to the high content of acetonitrile in the mobile phase in the 
system. That, of course, has an impact; however it could only justify a decrease in the acid/base strength and 
not an increase, as registered for etoposide.29,30  
These results demonstrated that log k’80 PLRP-S is very sensitive to ionization and could be used to 
determine the presence of ionization centers and their nature over a wide range of pH (1 to 12), for 
monitoring the ionization states of series of compounds in early stage of drug discovery when pKa are not yet 
measured. 
IMHB of ionized species detection by log k’80 PLRP-S  
Insights into the propensity of monoanions to form IMHBs could be obtained from the PLRP-S system. This 
is evident when log k’80 PLRP-S data of the three COMT inhibitors (entacapone, nitecapone and tolcapone) 
are analyzed (Figure 4A). The monoanionic forms are mostly present at neutral pH and have the propensity 
to form IMHBs as shown in Figure 5 for tolcapone as an example22. Their log k’80 PLRP-S is constant and 
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about 0.1. This value is considerably higher than values registered for all other anions (about -1.0), which do 
not have the propensity to form IMHBs. Here log k’80 PLRP-S provides information on the propensity of 
deprotonated acidic compounds to form IMHBs in nonpolar environments. 
 
Figure 5. Tolcapone (pKas = 4.64, 10.20) chemical structure in neutral form and IMHB in the monoanionic 
form 22 
 
 
Conclusion 
This study describes a fast chromatographic method to obtain a new physico-chemical index (log k’80 
PLRP-S) defining the lipophilicity of compounds in nonpolar environment such as the interior of a 
membrane. 
Since the propensity to form IMHBs is strongly dependent on the environment, this specific descriptor is 
expected to help highlight the propensity of neutral compounds to form IMHBs in different matrixes. The 
proposed log k’80 PLRP-S descriptor could be used in combination with existing tools (Δlog Poct-tol and 
EPSA) in drug discovery projects. 
Moreover, log k’80 PLRP-S is the only descriptor available today that provides information on the 
propensity of deprotonated acidic compounds to form IMHBs in nonpolar environments. 
Since log k’80 PLRP-S is very sensitive to ionization it could be used to determine the presence of ionization 
centers and their nature in nonpolar environments. The PLRP-S column stability over a wide range of pH (1 
to 12) allows for log k’80 PLRP-S to be used for monitoring the ionization states of series of compounds in 
early stage of drug discovery when pKa are not yet measured. 
Summing up, log k’80 PLRP-S provides unique information about the properties of drug candidates in a 
variety of different environments and warrants being integrated in drug discovery projects. 
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Supporting Information 
Tables 
 
Table S1. Experimental data for pairs in Figure 3.  
Compound 
ID 
logPoct logPtol Δlog Poct-tol IMHB δ DMSO-d6, 
ppm 
δ CDCl3, 
ppm 
logk'80 
PLRP-S 
m-nitrophenol 1.73 0.34 1.39 control  10.43 5.20 0.16 
o-nitrophenol 1.57 2.26 -0.69 sample 10.93 10.60 0.42 
cB5 1.91 1.96 -0.05 control  5.03 3.68 0.15 
c65 2.1* 2.1* 0 sample 7.53 7.64 0.42 
cD5 1.76 0.13 1.63 control  8.25 6.01 0.10 
c105 1.43 0.71 0.72 sample 10.51 10.37 0.11 
616 -0.34 -1.08 0.74 control  5.53 na -1.04 
516 -0.01 -0.29 0.28 sample 9.0 na -0.44 
416 4.8** 3.84*** 0.96 control  10.18 na -0.09 
316 5.6** 5.33*** 0.27 sample 12.15 na 0.32 
*  - uncertain value due to aggregation/quantification issues. 
** ElogD values 
***calclog Ptol 
When Δlog Poct-tol of the control is larger than Δlog Poct-tol of the sample, the sample has high propensity to 
form IMHB. This is verified for all pairs, except for cB/c6 for which an exceptional situation was found. 
 
Table S2. Measured pH for PLRP-S mobile phase  
Buffer  pH, aqueous portion 
s
wpH, 80% 
ACN  
0.1% formate 2.44 2.98 
0.1% Ammonium Acetate 6.74 7.69 
10 mM Triethylamine 12.06 10.93 
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Figures 
Figure S1. PCA scores (A) and loadings (B) plots 
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Figure S2. QSPR models external validation 
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